Teladoc Health, Inc.
TDOC NYSE· Services-Offices & Clinics Of Doctors Of Medicine
Last close · Oct 23, 2026
$6.34
KIRA · Stoqly’s AI analyst, in plain words
- Teladoc Health, Inc. had $2.5B of revenue in fiscal 2025, down 1.5% on the year before. Over five years, revenue changed +18.3% a year on average.
- Its operating margin was −10.4%, up 29.3 pts: of every 100 in sales, about −10 is left after running the business.
- Teladoc Health, Inc. lost $200M in fiscal 2025.
- Free cash flow was $285M in fiscal 2025, 11.3% of revenue.
Market cap
$1.1B
P/E
—
Revenue
$2.5B
Net income
−$200M
Free cash flow
$285M
Operating margin
−10.4%
Teladoc Health, Inc. in 30 seconds · fiscal 2025
Are sales growing?
−1.5%
No. Sales fell 1.5% last year.
Does it make a profit?
−7.9%
No. It lost money last year.
Does profit turn into cash?
11.3%
Yes. 11.3% of sales ends up as free cash.
How healthy are the accounts?
5 / 7
Mixed. It passes 5 of 7 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Teladoc Health, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 26, 2026
- Legal name
- Teladoc Health, Inc.
- CIK
- 0001477449
Teladoc Health, Inc. · TDOC
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $2.0B | $2.4B | $2.6B | $2.6B | $2.5B |
| Revenue growth | 85.8% | 18.4% | 8.1% | −1.3% | −1.5% |
| Net interest income | −$80.4M | −$9.3M | — | — | — |
| Gross margin | 68.0% | 69.1% | — | — | — |
| Operating margin | −13.1% | −567.3% | −9.6% | −39.7% | −10.4% |
| Net income | −$429M | −$13.7B | −$220M | −$1.0B | −$200M |
| Net margin | −21.1% | −567.5% | −8.5% | −39.0% | −7.9% |
| Diluted EPS | −$2.73 | −$84.60 | −$1.34 | −$5.87 | −$1.14 |
| Cash | |||||
| Cash from operations | $194M | $189M | $350M | $294M | $294M |
| Capital expenditure | $8.5M | $16.5M | $11.5M | $10.8M | $8.9M |
| Free cash flow | $185M | $173M | $339M | $283M | $285M |
| FCF margin | 9.1% | 7.2% | 13.0% | 11.0% | 11.3% |
| Share count change | 73.4% | 2.9% | 1.9% | 3.6% | 3.3% |
| Debt and strength | |||||
| Cash and short-term investments | $896M | $918M | $1.1B | $1.3B | $781M |
| Debt incl. finance leases | $0.0M | — | — | — | — |
| Shareholders' equity | $16.0B | $2.3B | $2.3B | $1.5B | $1.4B |
| Current ratio | 3.7x | 3.3x | 3.5x | 1.8x | 2.8x |
| Interest coverage | −3.3x | −622.2x | −11.2x | −42.9x | −13.3x |
| Returns and quality | |||||
| Return on capital | −1.4% | — | — | — | — |
| Return on equity | −2.7% | −148.8% | −9.5% | −52.5% | −13.9% |
| Piotroski F-score | 7 | 4 | 5 | 3 | 5 |
| Altman Z'' | 9.9 | −29.8 | −8.9 | −14.9 | −16.7 |
Insiders bought, 12 months
$0.1M
1 insider
Insiders sold, 12 months
$2.4M
6 insiders
Of sales under plans
21%
$0.5M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Teladoc Health, Inc. · TDOC
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $6.34 a share, the company is worth $1.1B.
Source: SEC EDGAR XBRL filings (CIK 0001477449). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.